Authors
Deepali Bisht, Denice P Rout, Wilson Poon
Published in
ACS applied bio materials. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Lipid nanoparticles (LNPs) are widely used for nucleic acid delivery, but current kit-based methods of measuring encapsulation efficiency quantify only total RNA and cannot distinguish between multiple nucleic acid cargos within co-formulated LNPs. This limitation complicates formulation characterization, dose normalization, reproducibility, and therapeutic predictability. To address this challenge, we developed LEGEND (LNP Encapsulation by Gel Electrophoresis and Nucleic Acid Densitometry), a simple gel-based assay that enables independent quantification of multiple nucleic acids in co-loaded LNP formulations. Using mCherry mRNA and eGFP siRNA as model cargos, we evaluated SM-102 and DLin-MC3-DMA LNPs containing varying siRNA/mRNA ratios. LEGEND separated and quantified individual nucleic acids based on size, revealing that experimentally encapsulated siRNA/mRNA ratios frequently differed from intended formulation ratios. Furthermore, encapsulation preferences varied between ionizable lipids, with SM-102 favoring mRNA encapsulation and DLin-MC3-DMA favoring siRNA encapsulation. Dose-normalized transfection studies in reporter cells demonstrated that these differences significantly influenced gene silencing and transgene expression outcomes. Overall, LEGEND provides a simple, accessible, and robust method for quantifying individual nucleic acid cargos in multi-nucleic acid co-formulated LNPs, enabling improved formulation characterization, quality control, and development of next-generation nucleic acid therapeutics.
PMID:
43038321
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0